Blood Safety
Cerus initiates Phase I clinical trial for Intercept blood system for red blood cells
Published in AIDS Weekly, October 9th, 2006
The red blood cell system has been developed to target and inactivate blood-borne pathogens while leaving the therapeutic properties of red blood cells intact. An estimated 34 million units of red blood cells are transfused worldwide each year to treat various indications ranging from severe trauma to genetic disorders.
The randomized, single-blind, controlled, multi-center Phase I study of the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2006-10-09)
More Articles from AIDS Weekly
- HIV/AIDS Epidemiology
HIV drug-resistant and nonsubtype B strains increasingly common in perinatally infected - HIV/AIDS Pathogenesis
Protection against X4-tropic HIV-1 superinfection involves CD4 HIV-1 Nef mechanisms - HIV/AIDS Prognostics
Time from HIV-1 seroconversion to CD4/CD8 ratio inversion predicts time to AIDS - HIV/AIDS Therapy
Interleukin-2 reconstitutes defective HIV- and CMV-specific CD8+ cell proliferation in HIV/AIDS - HIV/AIDS Transmission
Breastfeeding plus zidovudine reduces mortality rate at 7 months compared with formula feeding - Antifungals
Combination antifungal therapy valuable in pre-emptive management of high-risk patients - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
